Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 5 (2008), Issue 5 (May)

1. Keitel Functional Test for patients with rheumatoid arthritis: translation, reliability, validity, and responsiveness.
   Phys Ther, 88(5): 664-78. [Abstract] [Full-text]
2. Bmx regulates LPS-induced IL-6 and VEGF production via mRNA stability in rheumatoid synovial fibroblasts.
   Biochem Biophys Res Commun, 370(4): 599-602. [Abstract] [Full-text]
3. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
   Ann Rheum Dis, 67(6): 880-4. [Abstract] [Full-text]
4. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression.
   Ann Rheum Dis, 67(6): 794-800. [Abstract] [Full-text]
5. Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatment.
   Ann Rheum Dis, 67(6): 789-93. [Abstract] [Full-text]
6. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis.
   Ann Rheum Dis, 67(6): 801-7. [Abstract] [Full-text]
7. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.
   Ann Rheum Dis, 67(6): 769-74. [Abstract] [Full-text]
8. Distribution and clinical significance of blood dendritic cells in children with juvenile idiopathic arthritis.
   Ann Rheum Dis, 67(6): 762-8. [Abstract] [Full-text]
9. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
   Ann Rheum Dis, 67(6): 741-9. [Abstract] [Full-text]
10. Epistasis between the MHC and the RCA alpha block in primary Sjögren syndrome.
    Ann Rheum Dis, 67(6): 849-54. [Abstract] [Full-text]
11. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Ann Rheum Dis, 67(6): 815-22. [Abstract] [Full-text]
12. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Ann Rheum Dis, 67(6): 823-8. [Abstract] [Full-text]
13. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Ann Rheum Dis, 67(6): 860-6. [Abstract] [Full-text]
14. Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse.
    Ann Rheum Dis, 67(6): 750-7. [Abstract] [Full-text]
15. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
    Scand J Immunol, 67(6): 626-31. [Abstract] [Full-text]
16. Autonomic nervous symptoms in primary Sjogren's syndrome.
    Rheumatology (Oxford), 47(6): 914-9. [Abstract] [Full-text]
17. Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.
    Rheumatology (Oxford), 47(6): 868-71. [Abstract] [Full-text]
18. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
    Rheumatology (Oxford), 47(6): 828-33. [Abstract] [Full-text]
19. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes.
    Rheumatology (Oxford), 47(6): 834-9. [Abstract] [Full-text]
20. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.
    Rheumatology (Oxford), 47(6): 815-20. [Abstract] [Full-text]
21. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group.
    Rheumatology (Oxford), 47(6): 849-54. [Abstract] [Full-text]
22. Increased IL-4+ CD8+ T cells in peripheral blood and autoreactive CD8+ T cell lines of patients with inflammatory arthritis.
    Rheumatology (Oxford), 47(6): 795-803. [Abstract] [Full-text]
23. Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis.
    Rheumatology (Oxford), 47(6): 865-7. [Abstract] [Full-text]
24. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
    Rheumatology (Oxford), 47(6): 780-8. [Abstract] [Full-text]
25. Sweet and sour: the impact of sugars on disease.
    Rheumatology (Oxford), 47(6): 760-70. [Abstract] [Full-text]
26. Interleukin-7 in rheumatoid arthritis.
    Rheumatology (Oxford), 47(6): 753-9. [Abstract] [Full-text]
27. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Rheumatology (Oxford), 47(6): 771-6. [Abstract] [Full-text]
28. Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.
    Am J Med, 121(6): 532-8. [Abstract] [Full-text]
29. N-of-1 trials of expensive biological therapies: a third way?
    Arch Intern Med, 168(10): 1030-3. [Abstract] [Full-text]
30. Responsiveness of the Michigan Hand Outcomes Questionnaire--Dutch language version in patients with rheumatoid arthritis.
    Arch Phys Med Rehabil, 89(6): 1121-6. [Abstract] [Full-text]
31. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis.
    Atherosclerosis, 198(2): 332-7. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.